PL4066849T3 - Preparaty daptomycyny i ich zastosowania - Google Patents

Preparaty daptomycyny i ich zastosowania

Info

Publication number
PL4066849T3
PL4066849T3 PL22169277.5T PL22169277T PL4066849T3 PL 4066849 T3 PL4066849 T3 PL 4066849T3 PL 22169277 T PL22169277 T PL 22169277T PL 4066849 T3 PL4066849 T3 PL 4066849T3
Authority
PL
Poland
Prior art keywords
daptomycin preparations
daptomycin
preparations
Prior art date
Application number
PL22169277.5T
Other languages
English (en)
Inventor
Jim ALEXIOU
Noel Norris
Andrew Knill
Darryl Whittaker
Original Assignee
Hospira Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50277707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL4066849(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hospira Australia Pty Ltd filed Critical Hospira Australia Pty Ltd
Publication of PL4066849T3 publication Critical patent/PL4066849T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL22169277.5T 2012-09-11 2013-09-11 Preparaty daptomycyny i ich zastosowania PL4066849T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261699570P 2012-09-11 2012-09-11
US201361839699P 2013-06-26 2013-06-26

Publications (1)

Publication Number Publication Date
PL4066849T3 true PL4066849T3 (pl) 2025-06-16

Family

ID=50277707

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22169277.5T PL4066849T3 (pl) 2012-09-11 2013-09-11 Preparaty daptomycyny i ich zastosowania

Country Status (21)

Country Link
US (4) US9655946B2 (pl)
EP (2) EP2895187A4 (pl)
AU (2) AU2013316779A1 (pl)
BR (1) BR112015005400B1 (pl)
CA (1) CA2884484C (pl)
CL (1) CL2015000608A1 (pl)
CY (1) CY2200004T2 (pl)
DE (1) DE13837694T1 (pl)
DK (1) DK2895187T1 (pl)
ES (2) ES2552754T1 (pl)
HK (1) HK1207006A1 (pl)
HU (2) HUE071031T2 (pl)
IL (1) IL237652B (pl)
MX (1) MX366122B (pl)
NZ (3) NZ706286A (pl)
PL (1) PL4066849T3 (pl)
SA (1) SA515360129B1 (pl)
SG (1) SG11201506113WA (pl)
TN (1) TN2015000090A1 (pl)
WO (1) WO2014041425A1 (pl)
ZA (1) ZA201502310B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA37975B2 (fr) 2012-09-11 2021-03-31 Genzyme Corp Inhibiteurs de synthase de glucosylcéramide
EP2895187A4 (en) * 2012-09-11 2015-12-02 Hospira Australia Pty Ltd DAPTOMYCIN FORMULATIONS AND USES THEREOF
US10933019B2 (en) 2016-10-21 2021-03-02 Xellia Pharmaceuticals Aps Liquid formulations of daptomycin
JP7229999B2 (ja) 2017-08-31 2023-02-28 クセリア ファーマシューティカルズ エーピーエス ダプトマイシン製剤
CN110339342A (zh) * 2018-04-03 2019-10-18 江苏恒瑞医药股份有限公司 一种达托霉素的盐或含盐的组合物及其制备方法
US11058745B1 (en) 2018-10-04 2021-07-13 Good Health, Llc Stable liquid pharmaceutical compositions of daptomycin
US12527776B2 (en) 2019-02-04 2026-01-20 Genzyme Corporation Treatment of ciliopathies using inhibitors of glucosylceramide synthase (GCS)
JP7582205B2 (ja) * 2019-12-26 2024-11-13 ニプロ株式会社 ダプトマイシンを含有する安定した凍結乾燥製剤
EP4100009A1 (en) 2020-02-03 2022-12-14 Genzyme Corporation Methods for treating neurological symptoms associated with lysosomal storage diseases
CN115243675A (zh) 2020-03-12 2022-10-25 巴克斯特国际公司 含有山梨糖醇和甘露糖醇的组合的达托霉素制剂
KR20230043024A (ko) 2020-07-24 2023-03-30 젠자임 코포레이션 벤글루스타트를 포함하는 제약 조성물
CN115590825B (zh) * 2022-10-20 2024-02-02 安士制药(中山)有限公司 一种注射用达托霉素及其制备方法
CN120478324B (zh) * 2025-04-28 2025-12-26 暨南大学 泛酸或其药学上可接受的盐在制备增强病原菌对达托霉素的敏感性的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560906A (en) * 1995-03-27 1996-10-01 Oral Technology Laboratories, Inc. Non-alcoholic antimicrobial mouthwash for removal of dental plaque
DK1115417T3 (da) * 1998-09-25 2006-07-31 Cubist Pharm Inc Anvendelse af daptomycin
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
WO2002059145A1 (en) * 2000-12-18 2002-08-01 Cubist Pharmaceuticals, Inc. Methods for preparing purified lipopeptides
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
CN1616083A (zh) 2004-09-01 2005-05-18 魏雪纹 注射用达托霉素冻干制剂及制备方法
CA2610716A1 (en) * 2005-05-31 2006-12-07 Cubist Pharmaceuticals, Inc. Daptomycin for the treatment of biofilm and catheter salvage
WO2011062676A1 (en) 2009-11-23 2011-05-26 Eagle Pharmaceuticals, Inc. Formulations of daptomycin
PT2504353T (pt) 2009-11-23 2018-10-18 Cubist Pharmaceuticals Llc Composições de lipopéptido e métodos relacionados
JP2015526463A (ja) * 2012-08-23 2015-09-10 アギラ・スペシャルティーズ・プライベート・リミテッド 改善されたダプトマイシン注射用製剤
EP2895187A4 (en) * 2012-09-11 2015-12-02 Hospira Australia Pty Ltd DAPTOMYCIN FORMULATIONS AND USES THEREOF

Also Published As

Publication number Publication date
NZ742241A (en) 2019-08-30
DK2895187T1 (da) 2015-11-16
TN2015000090A1 (en) 2016-06-29
IL237652A0 (en) 2015-04-30
HUE071031T2 (hu) 2025-07-28
HK1207006A1 (en) 2016-01-22
WO2014041425A1 (en) 2014-03-20
EP4066849C0 (en) 2025-03-05
BR112015005400A2 (pt) 2017-07-04
EP2895187A4 (en) 2015-12-02
US10357535B2 (en) 2019-07-23
NZ706286A (en) 2018-05-25
EP4066849B1 (en) 2025-03-05
CA2884484A1 (en) 2014-03-20
NZ741342A (en) 2019-10-25
CA2884484C (en) 2021-01-19
ES3018415T3 (es) 2025-05-16
MX2015003164A (es) 2015-12-16
SG11201506113WA (en) 2015-09-29
IL237652B (en) 2020-06-30
AU2018217322B2 (en) 2020-08-27
AU2018217322A1 (en) 2018-09-06
US20170216396A1 (en) 2017-08-03
EP4066849A1 (en) 2022-10-05
DE13837694T1 (de) 2015-12-31
SA515360129B1 (ar) 2016-08-15
EP2895187A1 (en) 2015-07-22
US20150313958A1 (en) 2015-11-05
ES2552754T1 (es) 2015-12-02
CY2200004T2 (el) 2016-02-10
CL2015000608A1 (es) 2015-11-06
US9655946B2 (en) 2017-05-23
US20200237858A1 (en) 2020-07-30
BR112015005400B1 (pt) 2022-03-08
ZA201502310B (en) 2019-09-25
AU2013316779A1 (en) 2015-04-02
HUE13837694T1 (hu) 2016-04-28
MX366122B (es) 2019-06-27
US20180177843A1 (en) 2018-06-28

Similar Documents

Publication Publication Date Title
IL269045A (en) Aptamers and uses thereof
CL2014002899A1 (es) Composiciones pesticidas y procesos relacionados con ellas
BR112015003227A2 (pt) processos de clicoconjugação e composições
DK3360964T3 (da) Crispr-baseret genommodifikation og -regulering
IL238958A0 (en) Glutamase inhibitors, compositions comprising same and uses thereof
DK2920197T3 (da) Prolinlåste sammenhæftede peptider og anvendelser deraf
BR112015003354A2 (pt) composições e métodos de microcápsula
LT3470086T (lt) Pirolobenzodiazepinai ir jų konjugatai
EP2870505A4 (en) TRANSPARENT GLOSS AND GLOSS PROTECTION STRUCTURES
EP2930714A4 (en) Singing voice synthesizing system and singing voice synthesizing method
CO6801776A2 (es) Cosmético
PL2691443T3 (pl) Sprzężone lipomery i ich zastosowania
PL2766048T3 (pl) Pirolobenzodiazepiny i ich koniugaty
IL238227A0 (en) Anti-c16orf54 antibodies and methods of use thereof
PT2825573T (pt) Poliolefina telequélica e sua preparação
CL2014002051A1 (es) Composiciones plaguicidas y procesos relacionados con dichas composiones
EP4066849C0 (en) DAPTOMYCIN FORMULATIONS AND THEIR USES
BR112015011111A2 (pt) proteína multifuncional e formulação farmacêutica
PL2870247T3 (pl) Układ ekspresji i wydzielania
IL237135A0 (en) Peptide library and use thereof
EP2925338A4 (en) LYOPHILIZED FORMULATION OF TAT-NR2B9C
NL301064I2 (nl) toltrazuril en gleptoferron
BR112015007217A2 (pt) compostos e usos do composto
DK2849798T3 (da) Oligonukleotid-chelatkompleks-polypeptidsammensætninger og fremgangsmåder
PL2908831T3 (pl) Preparaty ziołowe